C I Westacott

Summary

Affiliation: University of Bristol
Country: UK

Publications

  1. ncbi Tumor necrosis factor alpha can contribute to focal loss of cartilage in osteoarthritis
    C I Westacott
    Department of Pathology and Microbiology, University of Bristol, Bristol, U K
    Osteoarthritis Cartilage 8:213-21. 2000
  2. ncbi The effects of pressure on chondrocyte tumour necrosis factor receptor expression
    C I Westacott
    Department of Pathology, University of Bristol Medical School, Bristol BS8 1TD, UK
    Biorheology 39:125-32. 2002
  3. ncbi Susceptibility to physiological concentrations of IL-1beta varies in cartilage at different anatomical locations on human osteoarthritic knee joints
    A F Barakat
    University of Mansoura Medical School, Mansoura, Egypt
    Osteoarthritis Cartilage 10:264-9. 2002

Collaborators

Detail Information

Publications3

  1. ncbi Tumor necrosis factor alpha can contribute to focal loss of cartilage in osteoarthritis
    C I Westacott
    Department of Pathology and Microbiology, University of Bristol, Bristol, U K
    Osteoarthritis Cartilage 8:213-21. 2000
    ..OBJECTIVE; To evaluate the potential for tumor necrosis factor alpha (TNFalpha)-induced focal loss of cartilage in osteoarthritic (OA) knee joints...
  2. ncbi The effects of pressure on chondrocyte tumour necrosis factor receptor expression
    C I Westacott
    Department of Pathology, University of Bristol Medical School, Bristol BS8 1TD, UK
    Biorheology 39:125-32. 2002
    ..These results suggest a mechanism whereby sensitivity of chondrocytes to the effects of TNFalpha may be increased, in susceptible individuals, in regions of the joint that experience peak loading...
  3. ncbi Susceptibility to physiological concentrations of IL-1beta varies in cartilage at different anatomical locations on human osteoarthritic knee joints
    A F Barakat
    University of Mansoura Medical School, Mansoura, Egypt
    Osteoarthritis Cartilage 10:264-9. 2002
    ..These results could have important implications for pharmacological intervention strategies...